What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - Estudio abierto, multicéntrico, de un solo grupo, poscomercialización (en ciertos países) para evaluar la eficacia, la seguridad y el efecto de la inmunogenicidad en la eficacia, la seguridad y la farmacocinética de Espesolimab i.v. en el tratamiento de pacientes con Psoriasis Pustulosa Generalizada (PPG) que presentan un brote recurrente después del tratamiento del brote inicial de PPG con Espesolimab i.v. Contact Protocol code: 1368-0120 EudraCT code: No aplica Pathology: Malalties de la pell i del teixit subcutani Principal investigator: Mollet Sánchez, Jordi Service: Dermatologia Phase: Fase III Recruiting: Closed Status: Iniciat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Interventional, randomised, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of intravenous (IV) eptinezumab in paediatric patients (6 to 17 years) for the preventive treatment of episodic migraine Contact Protocol code: 19357A EudraCT code: No aplica Pathology: Malalties del sistema nerviós Principal investigator: Pozo Rosich, Patricia Research group: Cefalea i dolor neurològic Service: Neurologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase 3, aleatorizado, doble ciego, para investigar la eficacia y seguridad de LY3502970 administrado una vez al día por vía oral en comparación con placebo en participantes adultos con obesidad o sobrepeso con comorbilidades relacionadas con el peso (ATTAIN-1) Contact Protocol code: J2A-MC-GZGP EudraCT code: No aplica Pathology: Malalties endocrines, nutricionals i metabòliques Principal investigator: Ciudin Mihai, Andreea Research group: Diabetis i metabolisme Service: Endocrinologia Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Estudio de fase II, multicéntrico, aleatorizado, con enmascaramiento doble, controlado con placebo y de 14 semanas de duración, con un periodo de tratamiento de 8 semanas, para evaluar la eficacia y la tolerabilidad de una dosis fija de BH-200 (250 mg dos veces al día) en pacientes ambulatorios con trastorno depresivo mayor (TDM) Contact Protocol code: BH-200-03 EudraCT code: 2022-002757-26 Pathology: Trastorns mentals i del comportament Principal investigator: Ramos Quiroga, José Antonio Research group: Psiquiatria, salut mental i addiccions Service: Psiquiatria Phase: Fase II Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A phase IIa, randomized, parallel, double-blind, Placebo Controlled Study to Evaluate the Efficacy and safety of enpatoran in dermatomyositis and polymyositis participants receiving standard of care. Contact Protocol code: MS200569_0041 EudraCT code: _ Pathology: Símptomes, signes i troballes anormals clíniques i de laboratori, no classificades enlloc més Principal investigator: Selva O'Callaghan, Albert Research group: Malalties sistèmiques Service: Medicina Interna Phase: Phase II Recruiting: Closed Status: Tancat Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Seguridad cardiovascular de 2,4 mg de cagrilintida s.c. en combinación con 2,4 mg de semaglutida s.c. (CagriSema 2,4 mg/2,4 mg s.c.) una vez a la semana en participantes con obesidad y enfermedad cardiovascular establecida Contact Protocol code: NN9838-4942 EudraCT code: 2021-005855-35 Pathology: Endocrine, nutritional and metabolic diseases Principal investigator: Ciudin Mihai, Andreea Research group: Diabetes and Metabolism Service: Endocrinology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack/Estudio de fase III, aleatorizado, doble ciego, controlado con placebo y de grupos paralelos para demostrar la eficacia y la seguridad de milvexian, un inhibidor oral del factor XIa, para la prevención de accidentes cerebrovasculares después de un accidente cerebrovascular isquémico agudo o un accidente isquémico transitorio de alto riesgo. Contact Protocol code: 70033093STR3001 EudraCT code: No aplica Principal investigator: Molina Cateriano, Carlos Research group: Recerca en ictus Service: Neurology Phase: Phase III Recruiting: Open Status: Open Contact Form Name* First surname* Second surname Email address* Telephone* Write your question* I have read and accept the data protection policy *. I have read and accept the data protection policy *. CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Controller: Fundació Hospital Universitari Vall Hebron Institut de Recerca – VHIR- G60594009.Purpose: Request for information on VHIR clinical research.Legitimation: Your consent. The data requested is necessary and your request cannot be processed if you do not provide them.Transfers: Your data will not be transferred to third parties except to the Principal Investigator who leads the research in order to be able to respond to your query.Data retention time: As long as they are useful for the purpose for which they were collected and responsibilities may arise.Rights: You can access, rectify, delete your data, oppose or limit its processing and request its portability, as well as revoke your consent without retroactive effects by contacting lopd@vhir.org. The revocation of consent and the opposition to the processing of your data will prevent the purpose from being carried out. DPO: dpd@ticsalutsocial.org. More information The request for information on a research project or clinical trial does not entail inclusion in it. Year 2024 Data d'inici Thu, 11 Jan 2024 - 12:00 Data de tancament Wed, 31 Jan 2024 - 12:00 Grup de recerca Cardiovascular Diseases Descripció 20240009_Predoctoral Researcher Cardiovascular Diseases Group Codi 2024-9 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0009//2024_0009_001.pdf Reclutant Inactiu Year 2024 Data d'inici Wed, 10 Jan 2024 - 12:00 Data de tancament Sun, 4 Feb 2024 - 12:00 Descripció 20240008_Digital Transformation Director Codi 2024-8 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0008//2024_0008_001.pdf Reclutant Inactiu Year 2024 Data d'inici Wed, 3 Jan 2024 - 12:00 Data de tancament Wed, 24 Jan 2024 - 12:00 Grup de recerca Infectious Diseases Descripció 20240005_Study coordinator / Data manager-Infectious Diseases Group. Codi 2024-5 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0005//2024_0005_001.pdf Reclutant Inactiu Year 2024 Data d'inici Wed, 3 Jan 2024 - 12:00 Data de tancament Wed, 17 Jan 2024 - 12:00 Grup de recerca Physiology and Pathophysiology of the Digestive Tract Descripció 20240006_Research Nurse-Physiology and Physiopathology of the digestive tract. Codi 2024-6 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0006//2024_0006_001.pdf Reclutant Inactiu Year 2024 Data d'inici Wed, 3 Jan 2024 - 12:00 Data de tancament Wed, 17 Jan 2024 - 12:00 Grup de recerca Psychiatry, Mental Health and Addictions Descripció 20230007_Support Technician in Research-Psychiatry, Mental Health and Addictions Research Group. Codi 2024-7 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0007//2024_0007_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 2 Jan 2024 - 12:00 Data de tancament Mon, 15 Jan 2024 - 12:00 Grup de recerca Neurovascular Diseases Descripció 2024001_Laboratory technician - Neurovascular diseases group Codi 2024-1 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0001//2024_0001_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 2 Jan 2024 - 12:00 Data de tancament Thu, 8 Feb 2024 - 12:00 Descripció Personnel Administration Officer/ Coordinator_2024003 Codi 2024-3 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0003//2024_0003_001.pdf Reclutant Inactiu Year 2024 Data d'inici Tue, 2 Jan 2024 - 12:00 Data de tancament Tue, 23 Jan 2024 - 12:00 Descripció 2024004_Study Coordinator Codi 2024-4 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0004//2024_0004_001.pdf Reclutant Inactiu Year 2023 Data d'inici Thu, 14 Dec 2023 - 12:00 Data de tancament Sun, 31 Dec 2023 - 12:00 Grup de recerca Biomedical Research in Urology Descripció Project manager _ Group in Urology Codi 2023-473 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0473//2023_0473_001.pdf Reclutant Inactiu Year 2023 Data d'inici Thu, 28 Dec 2023 - 12:00 Data de tancament Fri, 12 Jan 2024 - 12:00 Grup de recerca Microbiome Research Descripció 2023470_ Bioinformatic Technician Codi 2023-470 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0470//2023_0470_001.pdf Reclutant Inactiu Year 2023 Data d'inici Thu, 28 Dec 2023 - 12:00 Data de tancament Thu, 18 Jan 2024 - 12:00 Descripció IT Project Manager (Health – Hospital) Codi 2023-471 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0471//2023_0471_001.pdf Reclutant Inactiu Year 2023 Data d'inici Wed, 27 Dec 2023 - 12:00 Data de tancament Fri, 9 Feb 2024 - 12:00 Descripció International Pre-Award Research Manager_20230469 Codi 2023-469 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0469//2023_0469_001.pdf Reclutant Inactiu Year 2023 Data d'inici Fri, 22 Dec 2023 - 12:00 Data de tancament Fri, 12 Jan 2024 - 12:00 Descripció Business Development Team Lead Codi 2023-468 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0468//2023_0468_001.pdf Reclutant Inactiu Pagination First page « Previous page ‹ … Page 1565 Page 1566 Current page 1567 Page 1568 Page 1569 … Next page › Last page »
Year 2024 Data d'inici Thu, 11 Jan 2024 - 12:00 Data de tancament Wed, 31 Jan 2024 - 12:00 Grup de recerca Cardiovascular Diseases Descripció 20240009_Predoctoral Researcher Cardiovascular Diseases Group Codi 2024-9 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0009//2024_0009_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Wed, 10 Jan 2024 - 12:00 Data de tancament Sun, 4 Feb 2024 - 12:00 Descripció 20240008_Digital Transformation Director Codi 2024-8 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0008//2024_0008_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Wed, 3 Jan 2024 - 12:00 Data de tancament Wed, 24 Jan 2024 - 12:00 Grup de recerca Infectious Diseases Descripció 20240005_Study coordinator / Data manager-Infectious Diseases Group. Codi 2024-5 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0005//2024_0005_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Wed, 3 Jan 2024 - 12:00 Data de tancament Wed, 17 Jan 2024 - 12:00 Grup de recerca Physiology and Pathophysiology of the Digestive Tract Descripció 20240006_Research Nurse-Physiology and Physiopathology of the digestive tract. Codi 2024-6 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0006//2024_0006_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Wed, 3 Jan 2024 - 12:00 Data de tancament Wed, 17 Jan 2024 - 12:00 Grup de recerca Psychiatry, Mental Health and Addictions Descripció 20230007_Support Technician in Research-Psychiatry, Mental Health and Addictions Research Group. Codi 2024-7 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0007//2024_0007_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 2 Jan 2024 - 12:00 Data de tancament Mon, 15 Jan 2024 - 12:00 Grup de recerca Neurovascular Diseases Descripció 2024001_Laboratory technician - Neurovascular diseases group Codi 2024-1 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0001//2024_0001_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 2 Jan 2024 - 12:00 Data de tancament Thu, 8 Feb 2024 - 12:00 Descripció Personnel Administration Officer/ Coordinator_2024003 Codi 2024-3 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0003//2024_0003_001.pdf Reclutant Inactiu
Year 2024 Data d'inici Tue, 2 Jan 2024 - 12:00 Data de tancament Tue, 23 Jan 2024 - 12:00 Descripció 2024004_Study Coordinator Codi 2024-4 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2024//2024_0004//2024_0004_001.pdf Reclutant Inactiu
Year 2023 Data d'inici Thu, 14 Dec 2023 - 12:00 Data de tancament Sun, 31 Dec 2023 - 12:00 Grup de recerca Biomedical Research in Urology Descripció Project manager _ Group in Urology Codi 2023-473 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0473//2023_0473_001.pdf Reclutant Inactiu
Year 2023 Data d'inici Thu, 28 Dec 2023 - 12:00 Data de tancament Fri, 12 Jan 2024 - 12:00 Grup de recerca Microbiome Research Descripció 2023470_ Bioinformatic Technician Codi 2023-470 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0470//2023_0470_001.pdf Reclutant Inactiu
Year 2023 Data d'inici Thu, 28 Dec 2023 - 12:00 Data de tancament Thu, 18 Jan 2024 - 12:00 Descripció IT Project Manager (Health – Hospital) Codi 2023-471 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0471//2023_0471_001.pdf Reclutant Inactiu
Year 2023 Data d'inici Wed, 27 Dec 2023 - 12:00 Data de tancament Fri, 9 Feb 2024 - 12:00 Descripció International Pre-Award Research Manager_20230469 Codi 2023-469 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0469//2023_0469_001.pdf Reclutant Inactiu
Year 2023 Data d'inici Fri, 22 Dec 2023 - 12:00 Data de tancament Fri, 12 Jan 2024 - 12:00 Descripció Business Development Team Lead Codi 2023-468 URL Document vinculat http://vhir.vallhebron.com//DDGRecerca//OFERTESTREBALL//2023//2023_0468//2023_0468_001.pdf Reclutant Inactiu
